endoscopic retrograde cholangiopancreatography market insights, ercp market demand, ercp market growth, endoscopic retrograde cholangiopancreatography market analysis, endoscopic retrograde cholangiopancreatography market scope, ercp market research
At what pace is the endoscopic retrograde cholangiopancreatography (ercp) market growing, and what is its estimated value?
The endoscopic retrograde cholangiopancreatography (ERCP) market size has grown strongly in recent years. It will grow from $1.72 billion in 2024 to $1.87 billion in 2025 at a compound annual growth rate (CAGR) of 8.87%. The growth in the historic period can be attributed to the rising prevalence of various chronic gastrointestinal diseases, rising application of ERCP, rising incidence of pancreatic cancer, rising investments by governments, and the rise in medical tourism.
The endoscopic retrograde cholangiopancreatography (ERCP) market size is expected to see strong growth in the next few years. It will grow to $2.60 billion in 2029 at a compound annual growth rate (CAGR) of 8.58%. The growth in the forecast period can be attributed to the increasing prevalence of gastrointestinal conditions, rising incidence of cancer, growing focus on investments, increasing incidence of pancreatic duct, and rising demand for endoscopes. Major trends in the forecast period include technological advancements, partnerships for the R&D, expansion of the healthcare infrastructure, expansion of government healthcare, and development of advanced products.
Get Your Free Sample of The Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20770&type=smp
What are the top drivers to the rising demand in the endoscopic retrograde cholangiopancreatography (ercp) market?
The increasing prevalence of gastrointestinal conditions is expected to propel the growth of the endoscopic retrograde cholangiopancreatography (ERCP) market going forward. Gastrointestinal conditions refer to a broad range of disorders or diseases that affect the gastrointestinal (GI) tract, which includes the mouth, esophagus, stomach, small intestine, large intestine (colon), rectum, and anus, as well as accessory organs like the liver, gallbladder, and pancreas. The increasing prevalence of gastrointestinal conditions can be attributed to several factors, including dietary changes, an aging population, antibiotic use, lifestyle factors, and environmental influences. ERCP helps treat patients with gastrointestinal conditions by providing a minimally invasive method to diagnose and treat issues within the bile and pancreatic ducts, such as gallstones, strictures, tumors, or infections. For instance, in January 2024, according to the American Cancer Society, a US-based non-profit organization, it is estimated that there are about 26,890 new cases of stomach cancer in the United States with around 10,880 deaths expected from this type of cancer. Therefore, the increasing prevalence of gastrointestinal conditions is driving the growth of the endoscopic retrograde cholangiopancreatography (ERCP) market.
How is the endoscopic retrograde cholangiopancreatography (ercp) market segmented?
The endoscopic retrograde cholangiopancreatography (ERCP) market covered in this report is segmented –
1) By Product: Endoscopes, Endotherapy Devices, Visualization Systems, Energy Devices
2) By Disease Indication: Gastroesophageal Reflux Disease (GERD), Gastrointestinal Cancer, Barrett’s Esophagus, Bile Duct Diseases, Peptic Ulcer Disease, Crohn’s Disease, Intestinal Pseudo-Obstruction, Ogilvie Syndrome, Other Indications
3) By Application: Biliary Sphincterotomy, Biliary Dilatation, Biliary Stenting, Pancreatic Sphincterotomy, Pancreatic Duct Dilatation, Pancreatic Duct Stentin
4) By End User: Hospitals And Clinics, Ambulatory Surgery Centers, Other End Users
Subsegments:
1) By Endoscopes: Flexible Endoscopes, Semi-Rigid Endoscopes, High-Resolution Endoscopes
2) By Endotherapy Devices: Stone Extraction Devices, Balloon Dilatation Catheters, Stents, Biopsy Forceps
3) By Visualization Systems: High-Definition Visualization Systems, Endoscopic Imaging Systems, Video Endoscopes
4) By Energy Devices: Electrosurgical Devices, Laser Devices, Argon Plasma Coagulation Systems
Order your report now for swift delivery
Who are the top competitors in the endoscopic retrograde cholangiopancreatography (ercp) market?
Major companies operating in the endoscopic retrograde cholangiopancreatography (ERCP) market are Medtronic plc, Fujifilm Holdings Corporation, Siemens Healthineers AG, Stryker Corporation, Boston Scientific Corporation, B. Braun Melsungen AG, Olympus Corporation, Ottomed Endoscopy, W. L. Gore & Associates Inc., Streis plc, Cook Group, KARL STORZ SE & Co. KG, CONMED Corporation, PENTAX Medical Inc., AMBU Inc., Samsung Medison Co. Ltd., Medi-Globe GmbH, Telemed System Inc., Micro-Tech Endoscopy Inc., Hobbs Medical Inc., Shaili Endoscopy Pvt. Ltd.
What significant trends should we anticipate in the endoscopic retrograde cholangiopancreatography (ercp) market over the forecast period?
Major companies operating in the ERCP market are focusing on developing innovative technologies, such as the cholangioscope direct visualisation system, to provide advanced, high-resolution direct visualisation of the bile and pancreatic ducts. The cholangioscope direct visualization system is a medical device that provides advanced, high-resolution imaging of the bile and pancreatic ducts during ERCP procedures. For instance, in July 2024, Penlon Limited, a UK-based medical device company, launched the VedVision Cholangioscope Direct Visualisation System, an advanced medical device designed for high-resolution, direct visualization of the bile and pancreatic ducts, enhancing diagnosis and therapeutic intervention during ERCP procedures. It features a 2 mm accessory channel and a dedicated guidewire channel for secure access, supported by a full range of accessories such as biopsy forceps, stone extraction baskets, cytology brushes, and polypectomy snares.
Which regional trends are influencing the endoscopic retrograde cholangiopancreatography (ercp) market, and which area dominates the industry?
North America was the largest region in the endoscopic retrograde cholangiopancreatography (ERCP) market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the endoscopic retrograde cholangiopancreatography (ERCP) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Endoscopic Retrograde Cholangiopancreatography (ERCP) Market Report 2025 Offer?
The endoscopic retrograde cholangiopancreatography (ercp) market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Endoscopic retrograde cholangiopancreatography (ERCP) is a medical procedure that combines endoscopy and X-ray imaging to diagnose and treat conditions affecting the bile ducts, gallbladder, and pancreas. It involves guiding a flexible, lighted tube (endoscope) through the mouth to the small intestine, allowing physicians to examine these organs and address issues such as blockages or stones.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20770
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
